Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.094 | 0.3 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |